EVERSANA, Innovacell Partner to Advance ICEF15 Cell Therapy
CHICAGO, July 30, 2026 EVERSANA has been selected by Innovacell Inc. as its exclusive U.S. commercialization partner to support...
Life Sciences
Advertisement
GSK Invests £400M in Cambridge R&D Innovation Centre
LONDON, July 30, 2026 GSK has announced plans to establish a new global flagship research and development (R&D) centre...
Biohaven and Yale Secure Major Win in MODA Technology Dispute
NEW HAVEN, Conn., July 27, 2026 Biohaven Ltd. and Yale University have secured a significant legal victory after a...
ArkBio Completes Phase I Dosing of AK0406 Influenza Drug
SHANGHAI, July 23, 2026 ArkBio has successfully completed dosing across all cohorts in its Australian Phase I clinical trial...
Lundbeck Wins FDA Fast Track for Lu AH69593 in Narcolepsy
VALBY, Denmark, July 23, 2026 Lundbeck has received U.S. Food and Drug Administration (FDA) Fast Track designation for Lu...
Advertisements
Royalty Pharma Acquires Cliramitug Royalty Rights from Neurimmune
NEW YORK, July 22, 2026 Royalty Pharma plc has announced the acquisition of a portion of Neurimmune’s royalty interest...
Repligen’s $1.5B BioLife Deal Expands CGT Portfolio
WALTHAM, Mass. & BOTHELL, Wash., July 22, 2026 Repligen Corporation has announced a definitive agreement to acquire BioLife Solutions...
Bayer Secures €3 Billion Apollo Investment for LARC Business
LEVERKUSEN, Germany, July 10, 2026 Bayer AG has announced a landmark €3.0 billion equity investment agreement with global asset...
OTR Therapeutics and LG Chem Partner to Advance Oncology Therapies
SHANGHAI, China, July 8, 2026 OTR Therapeutics and LG Chem Life Sciences have announced a strategic collaboration to accelerate...
RoosterBio and Applied StemCell Partner to Scale iPSC Manufacturing
MILPITAS, Calif. & FREDERICK, Md., July 8, 2026 RoosterBio and Applied StemCell (ASC) have announced a strategic partnership to...
Advertisement
